Lung Protection During Radiotherapy Using Chitosan Microspheres
Radiation-Induced Pneumonitis as a Therapeutic Challenge
Radiotherapy remains one of the main pillars of modern cancer treatment. However, despite advances in precision targeting, damage to surrounding healthy tissue continues to pose a significant clinical problem - especially in thoracic malignancies. In such cases, the lungs represent a particularly radiosensitive organ.
Radiation-induced pneumonitis, an inflammatory response of lung tissue to ionizing radiation, often develops weeks after treatment and may present with symptoms such as coughing, dyspnea, and fever. In the long term, fibrotic remodeling can impair pulmonary function permanently.
Pathophysiologically, this condition involves a combination of oxidative stress, immune activation, and disruption of the alveolar barrier. Reactive oxygen species such as hydroxyl radicals trigger a cascade of tissue damage, including macrophage activation, release of proinflammatory cytokines such as TNF-α, IL-6, and TGF-β, and epithelial cell apoptosis. An effective protective strategy must therefore fulfill multiple roles: neutralizing free radicals, exerting anti-inflammatory effects, and being selectively active in irradiated lung tissue-without compromising the therapeutic efficacy of the radiation.
Chitosan Microspheres: Biopolymer-Based Targeting
This is precisely where an innovative approach using functionalized chitosan microspheres comes into play. In a preclinical study by Kim et al. (2023), researchers developed chitosan microspheres approximately 10 microns in diameter, specifically designed for targeted delivery to lung tissue. The surface of these particles was functionalized with 4-carboxyphenylboronic acid (4-CPBA), a ligand with high affinity for sialic acids-molecules abundantly expressed on the alveolar surface. This chemical modification enabled selective deposition of the microspheres in the lungs following intravenous administration.
The microspheres themselves consisted of ionotropically cross-linked chitosan, a biocompatible and biodegradable polymer increasingly used as a drug carrier in pharmaceutical technology. Their particle size was deliberately chosen-large enough to remain within the pulmonary circulation, yet small enough for systemic application.
Crocin: Antioxidant Protection with Synergistic Potential
The microspheres were loaded with crocin-a natural carotenoid derived from saffron. Crocin is well known for its antioxidant, anti-inflammatory, and cytoprotective properties. At the molecular level, crocin inhibits NF-KB activation, protects mitochondrial function, and upregulates endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px). As such, crocin specifically counteracts radiation-induced oxidative stress. Combining targeted pulmonary delivery with the potent antioxidant action of crocin results in a synergistic therapeutic approach, setting it apart from conventional systemic radioprotectors.
Study Results: Significant Pulmonary Protection in a Preclinical Model
The effects of this approach were clearly demonstrated in a murine model: mice receiving a single thoracic dose of 15 Gy and pre-treated with crocin-loaded chitosan microspheres developed significantly fewer cases of pneumonitis. Compared to control animals, the levels of proinflammatory cytokines in the lung tissue-particularly TNF-α, IL-6, and myeloperoxidase-were markedly reduced. Histological analysis revealed less inflammatory cell infiltration, decreased interstitial thickening, and reduced alveolar damage. Apoptosis was also significantly attenuated, as evidenced by decreased caspase-3 activity.
Most impressively, oxidative stress levels were substantially reduced: intracellular ROS in the lung tissue dropped by up to 70 % compared to untreated animals. Clinically relevant endpoints were also improved: the 30-day survival rate was 50 % higher in the microsphere-treated group-a strong signal of therapeutic benefit.
From Bench to Bedside: Opportunities and Challenges
These findings underscore the therapeutic potential of crocin-loaded chitosan microspheres as an adjunctive measure in thoracic radiotherapy. Their combination of targeted lung delivery, local radical scavenging, and anti-inflammatory action offers a promising means to reduce radiation side effects without impairing cancer treatment efficacy - a major advantage over nonspecific systemic agents.
Still, translating this concept into clinical practice remains a challenge. Key factors include the reproducible manufacturing of microspheres with consistent size and crocin loading, validation of targeting specificity in human tissue, thorough pharmacokinetic characterization, and assurance of no negative interaction with oncologic therapies. Immunological implications of repeated intravenous application must also be considered.
Conclusion: Lung-Protective Therapy Based on Biopolymer Technology
Despite existing challenges, it is clear that targeted radioprotection of the lungs using functionalized chitosan microspheres represents a promising approach with high innovation potential. This strategy combines modern materials science with pharmacological precision and may become an important tool in personalized radiotherapy—particularly for radiosensitive patients or those with high tumor burden in the thoracic region.
In the study, a chitosan with a molecular weight of 100 - 300 kDa and a degree of deacetylation (DDA) greater than 85% was used, cross-linked ionotropically with sodium tripolyphosphate. For successful clinical translation, precise documentation of such parameters is essential.
At Heppe Medical Chitosan, we support these requirements by providing high-purity, GMP-certified chitosan with fully specified DDA, molecular weight, and origin - ideal for preclinical research, pharmaceutical development, and regulatory-sensitive applications.
Interested? Contact us at:
References
Kim, J. et al. (2023). Crocin-loaded chitosan microspheres mitigate radiation-induced lung injury in mice. PubMed ID: 36781279
Rinaudo, M. (2006). Chitin and chitosan: Properties and applications. Progress in Polymer Science, 31(7), 603–632.
Kumar, M. N. V. R. (2000). A review of chitin and chitosan applications. Reactive and Functional Polymers, 46(1), 1–27.
First published on 14th of August 2025
Revised on 14th of August 2025